Cite
HARVARD Citation
Genovese, M. et al. (n.d.). P171 Efficacy and safety of upadacitinib in patients with active PsA and inadequate response to biologic DMARDs (SELECT-PsA-2): a double-blind, randomised controlled Phase III trial. Rheumatology. p. . [Online].